I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| classical monocyte | 15 studies | 25% ± 10% | |
| natural killer cell | 14 studies | 21% ± 5% | |
| non-classical monocyte | 11 studies | 24% ± 11% | |
| B cell | 11 studies | 21% ± 7% | |
| memory B cell | 10 studies | 22% ± 5% | |
| monocyte | 9 studies | 27% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 22% ± 5% | |
| naive B cell | 8 studies | 20% ± 4% | |
| myeloid cell | 7 studies | 24% ± 5% | |
| macrophage | 7 studies | 25% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 25% ± 5% | |
| dendritic cell | 6 studies | 28% ± 13% | |
| conventional dendritic cell | 4 studies | 29% ± 16% | |
| microglial cell | 4 studies | 22% ± 5% | |
| regulatory T cell | 4 studies | 18% ± 2% | |
| endothelial cell | 3 studies | 19% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| epithelial cell | 3 studies | 17% ± 0% | |
| mononuclear phagocyte | 3 studies | 19% ± 5% | |
| lymphocyte | 3 studies | 20% ± 4% | |
| germinal center B cell | 3 studies | 23% ± 3% | |
| innate lymphoid cell | 3 studies | 19% ± 3% | |
| gamma-delta T cell | 3 studies | 25% ± 8% | |
| T cell | 3 studies | 17% ± 2% |
